{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:32:03Z","timestamp":1787002323059,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1038\/bjc.2014.151","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T19:01:50Z","timestamp":1397761310000},"page":"2232-2245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma"],"prefix":"10.1038","volume":"110","author":[{"given":"J","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N H","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Aoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,17]]},"reference":[{"key":"BFbjc2014151_CR1","first-page":"1369","volume":"26","author":"VJ Amatya","year":"2011","unstructured":"Amatya VJ, Takeshima Y, Kushitani K, Yamada T, Morimoto C, Inai K (2011) Overexpression of CD26\/DPPIV in mesothelioma tissue and mesothelioma cell lines. Oncol Rep 26: 1369\u20131375.","journal-title":"Oncol Rep"},{"key":"BFbjc2014151_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-11-1990","volume":"18","author":"K Aoe","year":"2012","unstructured":"Aoe K, Amatya VJ, Fujimoto N, Ohnuma K, Hosono O, Hiraki A, Fujii M, Yamada T, Dang NH, Takeshima Y, Inai K, Kishimoto T, Morimoto C (2012) CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma. Clin Cancer Res 18: 1447\u20131456.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2014151_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000339259","volume":"83","author":"P Astoul","year":"2012","unstructured":"Astoul P, Roca E, Galateau-Salle F, Scherpereel A (2012) Malignant pleural mesothelioma: from the bench to the bedside. Respiration 83: 481\u2013493.","journal-title":"Respiration"},{"key":"BFbjc2014151_CR4","doi-asserted-by":"publisher","first-page":"30079","DOI":"10.1074\/jbc.M200438200","volume":"277","author":"M Beck","year":"2002","unstructured":"Beck M, Brickley K, Wilkinson HL, Sharma S, Smith M, Chazot PL, Pollard S, Stephenson FA (2002) Identification, molecular cloning, and characterization of a novel GABAA receptor-associated protein, GRIF-1. J Biol Chem 277: 30079\u201330090.","journal-title":"J Biol Chem"},{"key":"BFbjc2014151_CR5","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1016\/S0021-9258(19)86660-7","volume":"254","author":"SL Brenner","year":"1979","unstructured":"Brenner SL, Korn ED (1979) Substoichiometric concentrations of cytochalasin D inhibit actin polymerization. Additional evidence for an F-actin treadmill. J Biol Chem 254: 9982\u20139985.","journal-title":"J Biol Chem"},{"key":"BFbjc2014151_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/sonc.2002.30237","volume":"29","author":"M Britton","year":"2002","unstructured":"Britton M (2002) The epidemiology of mesothelioma. Semin Oncol 29: 18\u201325.","journal-title":"Semin Oncol"},{"key":"BFbjc2014151_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1749-6632.1994.tb17263.x","volume":"733","author":"C Bruns","year":"1994","unstructured":"Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoeffter P, Hoyer D, Lubbert H (1994) Molecular pharmacology of somatostatin-receptor subtypes. Ann NY Acad Sci 733: 138\u2013146.","journal-title":"Ann NY Acad Sci"},{"key":"BFbjc2014151_CR8","doi-asserted-by":"publisher","first-page":"28431","DOI":"10.1074\/jbc.M201261200","volume":"277","author":"AM Buchan","year":"2002","unstructured":"Buchan AM, Lin CY, Choi J, Barber DL (2002) Somatostatin, acting at receptor subtype 1, inhibits Rho activity, the assembly of actin stress fibers, and cell migration. J Biol Chem 277: 28431\u201328438.","journal-title":"J Biol Chem"},{"key":"BFbjc2014151_CR9","doi-asserted-by":"publisher","first-page":"52338","DOI":"10.1074\/jbc.M406185200","volume":"279","author":"CH Chien","year":"2004","unstructured":"Chien CH, Huang LH, Chou CY, Chen YS, Han YS, Chang GG, Liang PH, Chen X (2004) One site mutation disrupts dimer formation in human DPP-IV proteins. J Biol Chem 279: 52338\u201352345.","journal-title":"J Biol Chem"},{"key":"BFbjc2014151_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mce.2007.08.012","volume":"286","author":"T Florio","year":"2008","unstructured":"Florio T (2008) Somatostatin\/somatostatin receptor signalling: phosphotyrosine phosphatases. Mol Cell Endocrinol 286: 40\u201348.","journal-title":"Mol Cell Endocrinol"},{"key":"BFbjc2014151_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/bip.10256","volume":"66","author":"S Froidevaux","year":"2002","unstructured":"Froidevaux S, Eberle AN (2002) Somatostatin analogs and radiopeptides in cancer therapy. Biopolymers 66: 161\u2013183.","journal-title":"Biopolymers"},{"key":"BFbjc2014151_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2010.12.054","volume":"404","author":"FI Ghani","year":"2011","unstructured":"Ghani FI, Yamazaki H, Iwata S, Okamoto T, Aoe K, Okabe K, Mimura Y, Fujimoto N, Kishimoto T, Yamada T, Xu CW, Morimoto C (2011) Identification of cancer stem cell markers in human malignant mesothelioma cells. Biochem Biophys Res Commun 404: 735\u2013742.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFbjc2014151_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ccm.2012.12.005","volume":"34","author":"AR Haas","year":"2013","unstructured":"Haas AR, Sterman DH (2013) Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. Clin Chest Med 34: 99\u2013111.","journal-title":"Clin Chest Med"},{"key":"BFbjc2014151_CR14","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.2741\/2787","volume":"13","author":"PA Havre","year":"2008","unstructured":"Havre PA, Abe M, Urasaki Y, Ohnuma K, Morimoto C, Dang NH (2008) The role of CD26\/dipeptidyl peptidase IV in cancer. Front Biosci 13: 1634\u20131645.","journal-title":"Front Biosci"},{"key":"BFbjc2014151_CR15","first-page":"2031","volume":"7","author":"L Ho","year":"2001","unstructured":"Ho L, Aytac U, Stephens LC, Ohnuma K, Mills GB, McKee KS, Neumann C, LaPushin R, Cabanillas F, Abbruzzese JL, Morimoto C, Dang NH (2001) In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. Clin Cancer Res 7: 2031\u20132040.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2014151_CR16","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","volume":"13","author":"T Inamoto","year":"2007","unstructured":"Inamoto T, Yamada T, Ohnuma K, Kina S, Takahashi N, Yamochi T, Inamoto S, Katsuoka Y, Hosono O, Tanaka H, Dang NH, Morimoto C (2007) Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors. Clin Cancer Res 13: 4191\u20134200.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2014151_CR17","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1158\/1078-0432.CCR-06-0361","volume":"12","author":"T Inamoto","year":"2006","unstructured":"Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, Inamoto S, Tachibana M, Katsuoka Y, Dang NH, Morimoto C (2006) Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27kip1 enhancement, and disruption of binding to the extracellular matrix. Clin Cancer Res 12: 3470\u20133477.","journal-title":"Clin Cancer Res"},{"key":"BFbjc2014151_CR18","doi-asserted-by":"publisher","first-page":"12138","DOI":"10.1073\/pnas.211439098","volume":"98","author":"T Ishii","year":"2001","unstructured":"Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, Dang NH, Schlossman SF, Morimoto C (2001) CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc Natl Acad Sci USA 98: 12138\u201312143.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2014151_CR19","first-page":"120","volume":"4","author":"U Kumar","year":"2013","unstructured":"Kumar U (2013) G-Protein coupled receptors dimerization: diversity in somatostatin receptors subtypes. J Pharmacogenomics Pharmacoproteomics 4: 120\u2013129.","journal-title":"J Pharmacogenomics Pharmacoproteomics"},{"key":"BFbjc2014151_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/stem.592","volume":"29","author":"V Maguer-Satta","year":"2011","unstructured":"Maguer-Satta V, Besancon R, Bachelard-Cascales E (2011) Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells 29: 389\u2013396.","journal-title":"Stem Cells"},{"key":"BFbjc2014151_CR21","first-page":"473","volume":"30","author":"R Montironi","year":"2008","unstructured":"Montironi R, Cheng L, Mazzucchelli R, Morichetti D, Stramazzotti D, Santinelli A, Moroncini G, Galosi AB, Muzzonigro G, Comeri G, Lovisolo J, Cosciani-Cunico S, Bono AV (2008) Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. Cell Oncol 30: 473\u2013482.","journal-title":"Cell Oncol"},{"key":"BFbjc2014151_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-065X.1998.tb01571.x","volume":"161","author":"C Morimoto","year":"1998","unstructured":"Morimoto C, Schlossman SF (1998) The structure and function of CD26 in the T-cell immune response. Immunol Rev 161: 55\u201370.","journal-title":"Immunol Rev"},{"key":"BFbjc2014151_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MCP.0b013e328354acfe","volume":"18","author":"R Myers","year":"2012","unstructured":"Myers R (2012) Asbestos-related pleural disease. Curr Opin Pulm Med 18: 377\u2013381.","journal-title":"Curr Opin Pulm Med"},{"key":"BFbjc2014151_CR24","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1016\/S0021-9258(18)94108-6","volume":"264","author":"S Ogata","year":"1989","unstructured":"Ogata S, Misumi Y, Ikehara Y (1989) Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain. J Biol Chem 264: 3596\u20133601.","journal-title":"J Biol Chem"},{"key":"BFbjc2014151_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","volume":"29","author":"K Ohnuma","year":"2008","unstructured":"Ohnuma K, Dang NH, Morimoto C (2008) Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol 29: 295\u2013301.","journal-title":"Trends Immunol"},{"key":"BFbjc2014151_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2567.2002.01510.x","volume":"107","author":"K Ohnuma","year":"2002","unstructured":"Ohnuma K, Ishii T, Iwata S, Hosono O, Kawasaki H, Uchiyama M, Tanaka H, Yamochi T, Dang NH, Morimoto C (2002) G1\/S cell cycle arrest provoked in human T cells by antibody to CD26. Immunology 107: 325\u2013333.","journal-title":"Immunology"},{"key":"BFbjc2014151_CR27","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1074\/jbc.M609157200","volume":"282","author":"K Ohnuma","year":"2007","unstructured":"Ohnuma K, Uchiyama M, Yamochi T, Nishibashi K, Hosono O, Takahashi N, Kina S, Tanaka H, Lin X, Dang NH, Morimoto C (2007) Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1. J Biol Chem 282: 10117\u201310131.","journal-title":"J Biol Chem"},{"key":"BFbjc2014151_CR28","doi-asserted-by":"publisher","first-page":"14186","DOI":"10.1073\/pnas.0405266101","volume":"101","author":"K Ohnuma","year":"2004","unstructured":"Ohnuma K, Yamochi T, Uchiyama M, Nishibashi K, Yoshikawa N, Shimizu N, Iwata S, Tanaka H, Dang NH, Morimoto C (2004) CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. Proc Natl Acad Sci USA 101: 14186\u201314191.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"BFbjc2014151_CR29","doi-asserted-by":"publisher","first-page":"e86671","DOI":"10.1371\/journal.pone.0086671","volume":"9","author":"T Okamoto","year":"2014","unstructured":"Okamoto T, Iwata S, Yamada H, Hatano R, Komiya E, Dang NH, Ohnuma K, Morimoto C (2014) CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells. PLoS One 9 (1): e86671.","journal-title":"PLoS One"},{"key":"BFbjc2014151_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel YC (1999) Somatostatin and its receptor family. Front Neuroendocrinol 20: 157\u2013198.","journal-title":"Front Neuroendocrinol"},{"key":"BFbjc2014151_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12022-007-0014-8","volume":"18","author":"GM Portela-Gomes","year":"2007","unstructured":"Portela-Gomes GM, Stridsberg M, Grimelius L, Rorstad O, Janson ET (2007) Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas - predominance of receptor subtype 4. Endocr Pathol 18: 79\u201385.","journal-title":"Endocr Pathol"},{"key":"BFbjc2014151_CR32","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1210\/mend.11.8.9960","volume":"11","author":"DB Reardon","year":"1997","unstructured":"Reardon DB, Dent P, Wood SL, Kong T, Sturgill TW (1997) Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness. Mol Endocrinol 11: 1062\u20131069.","journal-title":"Mol Endocrinol"},{"key":"BFbjc2014151_CR33","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s002590100541","volume":"28","author":"JC Reubi","year":"2001","unstructured":"Reubi JC, Waser B, Schaer JC, Laissue JA (2001) Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 28: 836\u2013846.","journal-title":"Eur J Nucl Med"},{"key":"BFbjc2014151_CR34","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353: 1591\u20131603.","journal-title":"N Engl J Med"},{"key":"BFbjc2014151_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.282.5389.737","volume":"282","author":"SP Rohrer","year":"1998","unstructured":"Rohrer SP (1998) Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282: 737\u2013740.","journal-title":"Science"},{"key":"BFbjc2014151_CR36","doi-asserted-by":"publisher","first-page":"6950","DOI":"10.1158\/0008-5472.CAN-05-0647","volume":"65","author":"T Sato","year":"2005","unstructured":"Sato T, Yamochi T, Yamochi T, Aytac U, Ohnuma K, McKee KS, Morimoto C, Dang NH (2005) CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin \u03b21, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299. Cancer Res 65: 6950\u20136956.","journal-title":"Cancer Res"},{"key":"BFbjc2014151_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.soc.2012.12.004","volume":"22","author":"DD Shersher","year":"2013","unstructured":"Shersher DD, Liptay MJ (2013) Multimodality treatment of pleural mesothelioma. Surg Oncol Clin N Am 22: 345\u2013355.","journal-title":"Surg Oncol Clin N Am"},{"key":"BFbjc2014151_CR38","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.cellsig.2009.04.007","volume":"21","author":"RK Somvanshi","year":"2009","unstructured":"Somvanshi RK, Billova S, Kharmate G, Rajput PS, Kumar U (2009) C-tail mediated modulation of somatostatin receptor type-4 homo- and heterodimerizations and signaling. Cell Signal 21: 1396\u20131414.","journal-title":"Cell Signal"},{"key":"BFbjc2014151_CR39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.lungcan.2009.01.011","volume":"66","author":"Y Takeshima","year":"2009","unstructured":"Takeshima Y, Inai K, Amatya VJ, Gemba K, Aoe K, Fujimoto N, Kato K, Kishimoto T (2009) Accuracy of pathological diagnosis of mesothelioma cases in Japan: clinicopathological analysis of 382 cases. Lung Cancer 66: 191\u2013197.","journal-title":"Lung Cancer"},{"key":"BFbjc2014151_CR40","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1073\/pnas.95.8.4350","volume":"95","author":"S Tamura","year":"1998","unstructured":"Tamura S, Okumoto K, Toyama R, Shimozawa N, Tsukamoto T, Suzuki Y, Osumi T, Kondo N, Fujiki Y (1998) Human PEX1 cloned by functional complementation on a CHO cell mutant is responsible for peroxisome-deficient Zellweger syndrome of complementation group I. Proc Natl Acad Sci USA 95: 4350\u20134355.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2014151_CR41","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nrd1255","volume":"2","author":"G Weckbecker","year":"2003","unstructured":"Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2: 999\u20131017.","journal-title":"Nat Rev Drug Discov"},{"key":"BFbjc2014151_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2867-9-17","volume":"9","author":"K Yamada","year":"2009","unstructured":"Yamada K, Hayashi M, Du W, Ohnuma K, Sakamoto M, Morimoto C, Yamada T (2009) Localization of CD26\/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect. Cancer Cell Int 9: 17.","journal-title":"Cancer Cell Int"},{"key":"BFbjc2014151_CR43","doi-asserted-by":"publisher","first-page":"e62304","DOI":"10.1371\/journal.pone.0062304","volume":"8","author":"K Yamada","year":"2013","unstructured":"Yamada K, Hayashi M, Madokoro H, Nishida H, Du W, Ohnuma K, Sakamoto M, Morimoto C, Yamada T (2013) Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription. PLoS One 8: e62304.","journal-title":"PLoS One"},{"key":"BFbjc2014151_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbrc.2012.02.054","volume":"419","author":"H Yamazaki","year":"2012","unstructured":"Yamazaki H, Naito M, Ghani FI, Dang NH, Iwata S, Morimoto C (2012) Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells. Biochem Biophys Res Commun 419: 529\u2013536.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFbjc2014151_CR45","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1158\/0008-5472.CAN-04-2611","volume":"65","author":"T Yamochi","year":"2005","unstructured":"Yamochi T, Yamochi T, Aytac U, Sato T, Sato K, Ohnuma K, McKee KS, Morimoto C, Dang NH (2005) Regulation of p38 phosphorylation and topoisomerase II\u03b1 expression in the B-cell lymphoma line Jiyoye by CD26\/dipeptidyl Peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin. Cancer Res 65: 1973\u20131983.","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2014151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014151","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:22:19Z","timestamp":1684401739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2014151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["BFbjc2014151"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2014.151","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"20 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CM is an inventor of the humanised CD26 mAb, YS110 (US Patent #7402698). Y\u2019s Therapeutics Co., Ltd owns this patent, and CM and NHD are founding members of this company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}